Luye Pharma Says Five New Products Added to China's Drug Reimbursement List

MT Newswires Live

2025/12/08

Luye Pharma Group (HKG:2186) said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.

Shares of the company gained over 1% in morning trade Monday.

Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.

Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2589388084"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2589388084\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2589388084?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-08 11:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2589388084","market":"sh","top_or_hot":-1,"title":"Luye Pharma Says Five New Products Added to China's Drug Reimbursement List","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/LYPHF\">Luye Pharma</a> Group (HKG:2186) said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.</p><p>Shares of the company gained over 1% in morning trade Monday.</p><p>Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.</p><p>Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Luye Pharma Says Five New Products Added to China's Drug Reimbursement List</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLuye Pharma Says Five New Products Added to China's Drug Reimbursement List\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-08 11:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/LYPHF\">Luye Pharma</a> Group (HKG:2186) said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.</p><p>Shares of the company gained over 1% in morning trade Monday.</p><p>Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.</p><p>Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1583","symbol_name":"高瓴概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2589388084","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2589388084","pubTimestamp":1765163295,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Luye Pharma Group  said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.Shares of the company gained over 1% in morning trade Monday.Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1583":"高瓴概念","BK1606":"中医药概念","02186":"绿叶制药","BK1191":"制药"},"translate_title":"绿叶制药称中国药品报销目录新增5个产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02186":1},"content_text":"Luye Pharma Group (HKG:2186) said five new products were added to China's latest list of drugs eligible for reimbursement, according to a Hong Kong bourse filing Sunday.Shares of the company gained over 1% in morning trade Monday.Of the five products, opioid painkiller Mimeixin and schizophrenia treatment Ruibailai were added to China's National Reimbursement Drug List for the first time, while lung cancer treatment Zepzelca was included in the Commercial Insurance Innovative Drug List.Meanwhile, cancer drug Baituowei and chronic schizophrenia treatment Rykindo's inclusion was renewed, the firm said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}